BIOLOGICS CONGRESS 2015-A GLOBAL ENGAGE CONFERENCE BERLIN, GERMANY - FEBRUARY 2-3, 2015

The discovery and development of therapeutic antibodies to treat cancer or diseases of the immune system were the main subjects of the Biologics Congress 2015. Across the 2-day conference, approximately 150 participants, representing major European biopharmaceutical companies and visitors from the U.S., discussed the growth and development of the biologics market as more and more companies enter it. This report highlights presentations of interest from the 2 days.